(Q40479881)

20 September 2017

title

Tailored medicine: whom will it fit? The ethics of patient and disease stratification. (English)

1 reference

20 September 2017

0 references

0 references

3

Michael Parker

0 references

author name string

Andrew Smart

series ordinal

1

1 reference

20 September 2017

Paul Martin

series ordinal

2

1 reference

20 September 2017

publication date

1 August 2004

1 reference

20 September 2017

1 reference

20 September 2017

volume

18

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

322-342

1 reference

The new genetics in clinical practice

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Ethical and legal implications of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Ethical perspectives on pharmacogenomic profiling in the drug development process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Representation of South Asian people in randomised clinical trials: analysis of trials' data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Consent and privacy in pharmacogenetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Pharmacogenetics and the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Pharmacogenetics and future drug development and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

The economics of gene therapy and of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Population genetic structure of variable drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Racial differences in the response to drugs--pointers to genetic differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Molecular basis of ethnic differences in drug disposition and response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Ethical considerations in clinical pharmacogenomics research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Genetics. Toward a new vocabulary of human genetic variation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Pharmacogenetics, race, and ethnicity: social identities and individualized medical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

The medicalization of race: scientific legitimization of a flawed social construct

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

Spectre of racism in health and health care: lessons from history and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-8519.2004.00400.X

10.1111/J.1467-8519.2004.00400.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference